Expression of β-defensin-3 in lungs of immunocompetent rats with methicillin-resistant staphylococcus aureus ventilator-associated pneumonia

Journal of Surgical Research

Volumn 169, Issue 2, 2011, Pages 277-283

  Wu, Qingping ^a   Gui, Ping ^a   Yao, Shanglong ^a   Zhu, Hongfei ^a   Li, Jianrong ^b   Li, Yongping ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

defensin; methicillin resistant Staphylococcus aureus; model; ventilator associated pneumonia

Indexed keywords

BETA DEFENSIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGICAL PARAMETERS; MICROSCOPY; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TIDAL VOLUME; VENTILATOR ASSOCIATED PNEUMONIA; WESTERN BLOTTING;

ANIMALS; BETA-DEFENSINS; DISEASE MODELS, ANIMAL; IMMUNOCOMPETENCE; LUNG; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, VENTILATOR-ASSOCIATED; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY FUNCTION TESTS; STAPHYLOCOCCAL INFECTIONS; VENTILATORS, MECHANICAL;

EID: 79960220192     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.12.012     Document Type: Article

References (39)

1. M. Langer, P. Mosconi, and M. Cigada Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control Am Rev Respir Dis 140 1989 302
2. R. Celis, A. Torres, and J.M. Gatell Nosocomial pneumonia. A multivariate analysis of risk and prognosis Chest 93 1988 318
3. J.Y. Fagon, J. Chastre, and Y. Domart Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques Am Rev Respir Dis 139 1989 877
4. A. Torres, R. Aznar, and J.M. Gatell Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients Am Rev Respir Dis 142 1990 523
5. D.E. Craven, L.M. Kunches, and V. Kilinsky Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation Am Rev Respir Dis 133 1986 792
6. A. Tejada Artigas, S. Bello Dronda, and E. Chacon Valles Risk factors for nosocomial pneumonia in critically ill trauma patients Crit Care Med 29 2001 304
7. D.J. Cook, S.D. Walter, and R.J. Cook Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients Ann Intern Med 129 1998 433
8. M.R. Driks, D.E. Craven, and B.R. Celli Nosocomial pneumonia in intubated patients given sucralfate compared with antacids or histamine type 2 blockers. The role of gastric colonization N Engl J Med 317 1987 1376
9. A.M. Baker, J.W. Meredith, and E.F. Haponik Pneumonia in intubated trauma patients. Microbiology and outcomes Am J Respir Crit Care Med 153 1996 343
10. M.H. Kollef Ventilator-associated pneumonia. A multivariate analysis JAMA 1993 1965 270
11. J.F. Timsit, S. Chevret, and J. Valcke Mortality of nosocomial pneumonia in ventilated patients: Influence of diagnostic tools Am J Respir Crit Care Med 154 1996 116
12. J.Y. Fagon, J. Chastre, and A. Vuagnat Nosocomial pneumonia and mortality among patients in intensive care units JAMA 275 1996 866
13. M.E. Levison, and D. Kaye Pneumonia caused by gram-negative bacilli: An overview Rev Infect Dis 7 1985 S656
14. R.C. Spencer Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study Eur J Clin Microbiol Infect Dis 15 1996 281
15. J.L. Trouillet, J. Chastre, and A. Vuagnat Ventilator-associated pneumonia caused by potentially drug-resistant bacteria Am J Respir Crit Care Med 157 1998 531
16. C.A. Deryke, T.P. Lodise Jr., and M.J. Rybak Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia Chest 128 2005 1414
17. P.A. Moise, A. Forrest, and M.C. Birmingham The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin J Antimicrob Chemother 50 2002 1017
18. J. Fagon, H. Patrick, and D.W. Haas Treatment of gram-positive nosocomial pneumonia: Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group Am J Respir Crit Care Med 161 2000 753
19. E. Rubinstein, S. Cammarata, and T. Oliphant Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study Clin Infect Dis 32 2001 402
20. J. Harder, J. Bartels, and E. Christophers Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic J Biol Chem 276 2001 5707
21. J.R. Garcia, F. Jaumann, and S. Schulz Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction Cell Tissue Res 306 2001 257
22. M. Menten, S. Bailey, and F. Debone Pneumonia in children J Infect Dis 51 1932 254
23. J.J. Rouby, E. Martin De Lassale, and P. Poete Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects Am Rev Respir Dis 146 1992 1059
24. C.H. Marquette, F. Wallet, and M.C. Copin Relationship between microbiologic and histologic features in bacterial pneumonia Am J Respir Crit Care Med 154 1996 1784
25. P.E. Charles, L. Piroth, and N. Desbiolles New model of ventilator-associated pneumonia in immunocompetent rabbits Crit Care Med 30 2002 2278
26. C.H. Marquette, D. Wermert, and F. Wallet Characterization of an animal model of ventilator-acquired pneumonia Chest 115 1999 200
27. A. Torres, M. el-Ebiary, and L. Padro Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediately post mortem pulmonary biopsy Am J Crit Care Med 149 1994 324
28. N. Fabregas, A. Torres, and M. el-Ebiary Histopathologic and microbiologic aspects of ventilator-associated pneumonia Anesthesiology 84 1996 60
29. D.L. George, P.S. Falk, and R.G. Wunderink Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling Am J Respir Crit Care Med 158 1998 1839
30. A. Torres, J. Serra-Batlles, and E. Ros Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: The effect of body position Ann Intern Med 116 1992 540
31. J. Ibanez, A. Penafiel, and P. Marse Incidence of gastroesophageal reflux and aspiration in mechanically ventilated patients using small-bore nasogastric tubes JPEN J Parenter Enteral Nutr 24 2000 103
32. R.J. Koerner Contribution of endotracheal tubes to the pathogenesis of ventilator-associated pneumonia J Hosp Infect 35 1997 83
33. L. Holzapfel, C. Chastang, and G. Demingeon A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia Am J Respir Crit Care Med 159 1999 695
34. T.A. Goularte, M. Manning, and D.E. Craven Bacterial colonization in humidifying cascade reservoirs after 24 and 48 hours of continuous mechanical ventilation Infect Control 8 1987 200
35. K.M. Huttner, and C.L. Bevins Antimicrobial peptides as mediators of epithelial host defense Pediatr Res 45 1999 785
36. R.L. Gallo, and K.M. Huttner Antimicrobial peptides: An emerging concept in cutaneous biology J Invest Dermatol 111 1998 739
37. A. Takaoka, and H. Yanai Interferon signaling network in innate defense Cell Microbiol 8 2006 907
38. H. Ishimoto, H. Mukae, and Y. Date Identification of hBD-3 in respiratory tract and serum: The increase in pneumonia Eur Respir J 27 2006 253
39. G. Ping, W. Qingping, and Y. Shanglong Effects of mechanical stretch on the expression of human β-defensin-3 in alveolar epithelial cells elicited by interferon-gamma Chin J Emerg Med 17 2008 606